Evolus Inc Stock Analysis

Evolus Stock Analysis Notes

About 13.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.08. Evolus Inc had not issued any dividends in recent years. Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. The company was incorporated in 2012 and is headquartered in Newport Beach, California. Evolus operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 174 people. To learn more about Evolus Inc call Murthy Simhambhatla at (949) 284-4555 or check out https://www.evolus.com.

Evolus Inc Investment Alerts

Evolus Inc Upcoming and Recent Events

Evolus Largest EPS Surprises

View All Earnings Estimates

Evolus Stock Institutional Investors

Note, although Evolus' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Evolus Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 710.91 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Evolus's market, we take the total number of its shares issued and multiply it by Evolus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Evolus Profitablity

The company has Profit Margin (PM) of (0.31) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.08) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.08.

Management Efficiency

Evolus Inc has return on total asset (ROA) of (0.123) % which means that it has lost $0.123 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (12.7929) %, meaning that it created substantial loss on money invested by shareholders. Evolus' management efficiency ratios could be used to measure how well Evolus manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to gain to 3.13 in 2024, whereas Return On Tangible Assets are likely to drop (0.54) in 2024. At this time, Evolus' Total Assets are comparatively stable compared to the past year. Intangibles To Total Assets is likely to gain to 0.57 in 2024, whereas Non Current Assets Total are likely to drop slightly above 63.4 M in 2024.

Technical Drivers

As of the 19th of April, Evolus shows the Downside Deviation of 2.47, mean deviation of 2.14, and Coefficient Of Variation of 1674.87. Evolus Inc technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Evolus Inc, which can be compared to its peers. Please confirm Evolus Inc coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Evolus Inc is priced favorably, providing market reflects its regular price of 11.53 per share. Given that Evolus has jensen alpha of 0.1412, we urge you to verify Evolus Inc's prevailing market performance to make sure the company can sustain itself at a future point.

Evolus Inc Price Movement Analysis

Evolus Inc Insider Trading Activities

Evolus Predictive Daily Indicators

Evolus Corporate Filings

Evolus Forecast Models

Evolus' time-series forecasting models are one of many Evolus' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Evolus' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Evolus prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Evolus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Evolus. By using and applying Evolus Stock analysis, traders can create a robust methodology for identifying Evolus entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Evolus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Evolus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Evolus Inc stock analysis indicators help investors evaluate how Evolus stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Evolus shares will generate the highest return on investment. By understating and applying Evolus stock analysis, traders can identify Evolus position entry and exit signals to maximize returns.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.

Is Evolus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolus. If investors know Evolus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Evolus Inc is measured differently than its book value, which is the value of Evolus that is recorded on the company's balance sheet. Investors also form their own opinion of Evolus' value that differs from its market value or its book value, called intrinsic value, which is Evolus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolus' market value can be influenced by many factors that don't directly affect Evolus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Evolus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.